Tate & Lyle Ventures is Lumora's major shareholder having previously backed the company.
UK-listed sugar company Tate & Lyle’s corporate venturing unit has invested £500,000 ($825,000) in the series B round for Lumora, which tests molecules for use in the food sector.
Tate & Lyle Ventures is Lumora’s major shareholder having previously backed the company.
A further £1m in the round came from venture capital firm Catapult Venture Managers.
The money will be used to help UK-based Lumora enter the clinical molecular diagnostic market, such as an integrated testing station for…
